Bill Search

  • Introduced
    Jan 21, 2022
  • Passed Senate
    Mar 10, 2022
  • Passed House
    Mar 31, 2022
  • Signed into Law
SB 353
Maryland Senate Bill
Did you know we offer free bill tracking in Congress and 50 states, and a great mobile app? Sign up here
Health Insurance - Prescription Insulin Drugs - Limits on Copayment and Coinsurance (Insulin Cost Reduction Act)
Last Action See all actions
executive • May 27, 2022: Vetoed by the Governor (Duplicative)

Official Summary/Bill Text

Comments on SB 353

Tweets

Whip Lists

Sponsors
Votes
Actions
  • May 27, 2022 | executive
    • Vetoed by the Governor (Duplicative)
  • Mar 31, 2022 | Senate
    • Returned Passed
  • Mar 31, 2022 | House
    • Third Reading Passed (125-0)
  • Mar 30, 2022 | House
    • Favorable Report by Health and Government Operations
    • Favorable Adopted Second Reading Passed
  • Mar 18, 2022 | House
    • Hearing 3/24 at 1:30 p.m.
  • Mar 11, 2022 | House
    • Referred Health and Government Operations
  • Mar 10, 2022 | Senate
    • Third Reading Passed (47-0)
  • Mar 08, 2022 | Senate
    • Favorable with Amendments {173122/1 Adopted
    • Second Reading Passed with Amendments
  • Mar 07, 2022 | Senate
    • Favorable with Amendments Report by Finance
  • Jan 26, 2022 | Senate
    • Hearing 2/09 at 1:00 p.m.
  • Jan 21, 2022 | Senate
    • First Reading Finance